COGT
Price
$4.81
Change
-$0.17 (-3.41%)
Updated
May 9 closing price
Capitalization
547.65M
93 days until earnings call
KNSA
Price
$26.03
Change
-$0.69 (-2.58%)
Updated
May 9 closing price
Capitalization
1.9B
79 days until earnings call
Ad is loading...

COGT vs KNSA

Header iconCOGT vs KNSA Comparison
Open Charts COGT vs KNSABanner chart's image
Cogent Biosciences
Price$4.81
Change-$0.17 (-3.41%)
Volume$708.72K
Capitalization547.65M
Kiniksa Pharmaceuticals International
Price$26.03
Change-$0.69 (-2.58%)
Volume$272.07K
Capitalization1.9B
COGT vs KNSA Comparison Chart
Loading...
COGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KNSA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
COGT vs. KNSA commentary
May 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COGT is a StrongBuy and KNSA is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
May 12, 2025
Stock price -- (COGT: $4.81 vs. KNSA: $26.03)
Brand notoriety: COGT and KNSA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: COGT: 53% vs. KNSA: 41%
Market capitalization -- COGT: $547.65M vs. KNSA: $1.9B
COGT [@Biotechnology] is valued at $547.65M. KNSA’s [@Biotechnology] market capitalization is $1.9B. The market cap for tickers in the [@Biotechnology] industry ranges from $296.96B to $0. The average market capitalization across the [@Biotechnology] industry is $2.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COGT’s FA Score shows that 0 FA rating(s) are green whileKNSA’s FA Score has 1 green FA rating(s).

  • COGT’s FA Score: 0 green, 5 red.
  • KNSA’s FA Score: 1 green, 4 red.
According to our system of comparison, KNSA is a better buy in the long-term than COGT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COGT’s TA Score shows that 5 TA indicator(s) are bullish while KNSA’s TA Score has 6 bullish TA indicator(s).

  • COGT’s TA Score: 5 bullish, 3 bearish.
  • KNSA’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, both COGT and KNSA are a good buy in the short-term.

Price Growth

COGT (@Biotechnology) experienced а -18.06% price change this week, while KNSA (@Biotechnology) price change was -5.86% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.25%. For the same industry, the average monthly price growth was +9.40%, and the average quarterly price growth was -13.49%.

Reported Earning Dates

COGT is expected to report earnings on Aug 12, 2025.

KNSA is expected to report earnings on Jul 29, 2025.

Industries' Descriptions

@Biotechnology (-6.25% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KNSA($1.9B) has a higher market cap than COGT($548M). KNSA YTD gains are higher at: 31.598 vs. COGT (-38.333). KNSA has higher annual earnings (EBITDA): -43.92M vs. COGT (-271.59M). COGT has more cash in the bank: 287M vs. KNSA (244M). KNSA has less debt than COGT: KNSA (9.86M) vs COGT (17.5M). KNSA has higher revenues than COGT: KNSA (423M) vs COGT (0).
COGTKNSACOGT / KNSA
Capitalization548M1.9B29%
EBITDA-271.59M-43.92M618%
Gain YTD-38.33331.598-121%
P/E RatioN/A164.54-
Revenue0423M-
Total Cash287M244M118%
Total Debt17.5M9.86M178%
FUNDAMENTALS RATINGS
COGT vs KNSA: Fundamental Ratings
COGT
KNSA
OUTLOOK RATING
1..100
3921
VALUATION
overvalued / fair valued / undervalued
1..100
82
Overvalued
84
Overvalued
PROFIT vs RISK RATING
1..100
7561
SMR RATING
1..100
9993
PRICE GROWTH RATING
1..100
6538
P/E GROWTH RATING
1..100
1001
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

COGT's Valuation (82) in the Miscellaneous industry is in the same range as KNSA (84) in the Pharmaceuticals Major industry. This means that COGT’s stock grew similarly to KNSA’s over the last 12 months.

KNSA's Profit vs Risk Rating (61) in the Pharmaceuticals Major industry is in the same range as COGT (75) in the Miscellaneous industry. This means that KNSA’s stock grew similarly to COGT’s over the last 12 months.

KNSA's SMR Rating (93) in the Pharmaceuticals Major industry is in the same range as COGT (99) in the Miscellaneous industry. This means that KNSA’s stock grew similarly to COGT’s over the last 12 months.

KNSA's Price Growth Rating (38) in the Pharmaceuticals Major industry is in the same range as COGT (65) in the Miscellaneous industry. This means that KNSA’s stock grew similarly to COGT’s over the last 12 months.

KNSA's P/E Growth Rating (1) in the Pharmaceuticals Major industry is significantly better than the same rating for COGT (100) in the Miscellaneous industry. This means that KNSA’s stock grew significantly faster than COGT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
COGTKNSA
RSI
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
85%
Bearish Trend 3 days ago
82%
Momentum
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
70%
MACD
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
74%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
76%
Advances
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 11 days ago
74%
Declines
ODDS (%)
Bearish Trend 6 days ago
84%
Bearish Trend 3 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
80%
Aroon
ODDS (%)
Bearish Trend 3 days ago
81%
Bullish Trend 3 days ago
77%
View a ticker or compare two or three
Ad is loading...
COGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KNSA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TSLA298.2613.44
+4.72%
Tesla
GME27.540.76
+2.84%
GameStop Corp
BTC.X104696.3300001725.468800
+1.68%
Bitcoin cryptocurrency
AAPL198.531.04
+0.53%
Apple
SPY564.34-0.72
-0.13%
SPDR® S&P 500® ETF

COGT and

Correlation & Price change

A.I.dvisor indicates that over the last year, COGT has been loosely correlated with HOFBF. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if COGT jumps, then HOFBF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COGT
1D Price
Change %
COGT100%
-3.41%
HOFBF - COGT
63%
Loosely correlated
N/A
TNFA - COGT
55%
Loosely correlated
-3.36%
XNCR - COGT
52%
Loosely correlated
-5.23%
ETNB - COGT
52%
Loosely correlated
-1.16%
ARWR - COGT
51%
Loosely correlated
-1.66%
More

KNSA and

Correlation & Price change

A.I.dvisor indicates that over the last year, KNSA has been loosely correlated with BEAM. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if KNSA jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KNSA
1D Price
Change %
KNSA100%
-2.58%
BEAM - KNSA
36%
Loosely correlated
+0.93%
RGNX - KNSA
36%
Loosely correlated
+5.17%
COGT - KNSA
35%
Loosely correlated
-3.41%
ETNB - KNSA
35%
Loosely correlated
-1.16%
COYA - KNSA
35%
Loosely correlated
-2.58%
More